This UroGen Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Author: Avi Kapoor | April 16, 2025 08:27am

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Scotiabank analyst Allan Verkhovski initiated coverage on Paylocity Holding Corporation (NASDAQ:PCTY) with a Sector Perform rating and announced a price target of $190. Paylocity shares closed at $186.75 on Tuesday. See how other analysts view this stock.
Chardan Capital analyst Keay Nakae initiated coverage on Korro Bio, Inc. (NASDAQ:KRRO) with a Buy rating and announced a price target of $25. Korro Bio shares closed at $13.40 on Tuesday. See how other analysts view this stock.
Scotiabank initiated coverage on CG Oncology, Inc. (NASDAQ:CGON) with a Sector Perform rating and announced a price target of $23. CG Oncology shares closed at $20.11 on Tuesday. See how other analysts view this stock.
Scotiabank initiated coverage on UroGen Pharma Ltd. (NASDAQ:URGN) with a Sector Outperform rating and announced a price target of $23. UroGen Pharma shares closed at $10.75 on Tuesday. See how other analysts view this stock.
Scotiabank analyst George Farmer initiated coverage on Protara Therapeutics, Inc. (NASDAQ:TARA) with a Sector Outperform rating and announced a price target of $12. Protara Therapeutics shares closed at $4.17 on Tuesday. See how other analysts view this stock.